Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-10-19Clinical Trial Update: Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate [Phase 3]
Phase III study evaluating safety and efficacy of Fermagate with Lanthanum Carbonate for chronic kidney disease has been terminated.
-
CLINICAL_TRIALS withdrawal · 2010-10-19Clinical Trial Update: Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride [Phase 3]
Phase 3 trial evaluating Fermagate in combination with Sevelamer Hydrochloride for chronic kidney disease was terminated.
-
FDA approval · 2010-10-18FDA Approved: LASIX — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental application for LASIX (furosemide) from Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2010-10-07Clinical Trial Update: Correlations Between BNP & Dry Weight, and Between Troponin & Mortality, in Hemodialysis Patients
This clinical trial update evaluates correlations between BNP and dry weight, and between troponin and mortality, in hemodialysis patients.
-
CLINICAL_TRIALS trial_result · 2010-10-05Clinical Trial Update: Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys [Phase 2]
A Phase 2 trial evaluating Campath-1H (alemtuzumab) for preventing kidney transplant rejection has completed, with results posted in 2010.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-09-28Clinical Trial Update: A Study of Cytokine and Inflammatory Markers in Patients With Chronic Renal Failure
A completed clinical trial evaluating cytokine and inflammatory markers in patients with chronic kidney disease.
-
CLINICAL_TRIALS research · 2010-09-17Clinical Trial Update: Exploring Life Experience and Lifestyle Intervention Program Among Patients With Chronic Kidney Disease: A Longitudinal Study [NA]
A longitudinal study examining life experiences and a lifestyle intervention program for patients with chronic kidney disease, sponsored by …
-
CLINICAL_TRIALS trial_result · 2010-09-14Clinical Trial Update: The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors [Phase 2]
Phase 2 trial evaluating paricalcitol capsules for reducing albuminuria in patients with type 2 diabetic nephropathy on renin-angiotensin sy…
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Lifestyle Modifications and the Progression of Chronic Kidney Disease [NA]
This document notes the completion of a clinical trial evaluating whether lifestyle modifications influence the progression of chronic kidne…
-
CLINICAL_TRIALS trial_result · 2010-08-04Clinical Trial Update: The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5 [Phase 3]
A Phase 3 trial (PRIMO II) evaluated paricalcitol injections for renal failure–induced cardiac morbidity in CKD Stage 5 patients. The study …
-
CLINICAL_TRIALS trial_result · 2010-08-02Clinical Trial Update: An Evaluation of the Causes of Anemia in Patients With Heart Failure
A completed clinical trial evaluating the causes of anemia in patients with heart failure, including those with chronic kidney disease.
-
FDA approval · 2010-07-28FDA Approved: HUMATROPE — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMATROPE (somatropin) submitted by Eli Lilly and Company, authorizing changes to the existing p…
-
CLINICAL_TRIALS research · 2010-07-27Clinical Trial Update: NAC in Preventing CIN in CRF Patients Who Need Enhanced CT Scan in ED [Phase 4]
A Phase 4 trial at Seoul National University Hospital is evaluating whether N-acetylcysteine can prevent contrast-induced nephropathy in pat…
-
CLINICAL_TRIALS trial_result · 2010-07-23Clinical Trial Update: An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED) [Phase 3]
Phase 3 trial evaluating an investigational drug in patients with type 2 diabetes mellitus and chronic kidney disease has completed and resu…
-
CLINICAL_TRIALS research · 2010-07-20Clinical Trial Update: The Prevention of Contrast Induced Nephropathy by Sarpogrelate in Patients With Chronic Kidney Disease [Phase 4]
This document reports a Phase 4 clinical trial evaluating whether sarpogrelate can prevent contrast-induced nephropathy in patients with chr…
-
CLINICAL_TRIALS trial_result · 2010-07-14Clinical Trial Update: Fibroblast Growth Factor-23 (FGF-23) is Independently Associated With Left Ventricular Mass Index (LVMI) and Myocardial Performance Index (MPI) in Haemodialysis Patients
A clinical trial update indicates that fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass i…
-
CLINICAL_TRIALS trial_result · 2010-07-13Clinical Trial Update: The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis [Phase 3]
Phase 3 trial evaluating somatropin in adults on chronic dialysis was terminated, with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-07-08Clinical Trial Update: Uric Acid and Long-term Outcomes in Chronic Kidney Disease
A completed clinical trial update examining how uric acid levels relate to long-term outcomes in chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2010-07-08Clinical Trial Update: Analysis of Emergency Department (ED) Volumes During Natural Disasters
This completed clinical trial update analyzes emergency department volumes during natural disasters, conducted by The University of Texas He…
-
CLINICAL_TRIALS research · 2010-07-07Clinical Trial Update: Targeting Peroxisome Proliferator-activated Receptor-gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients? [NA]
A clinical trial update exploring targeting PPAR-gamma in peritoneal dialysis patients to reduce inflammation, atherosclerosis, and calcific…
-
CLINICAL_TRIALS trial_result · 2010-07-07Clinical Trial Update: Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide [Phase 4]
Phase 4 trial comparing iodixanol and iopromide for contrast-induced nephrotoxicity in patients with chronic kidney disease undergoing coron…
-
CLINICAL_TRIALS trial_result · 2010-07-07Clinical Trial Update: The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease [Phase 4]
Phase 4 clinical trial update examining whether AST-120 improves endothelial dysfunction in patients with chronic kidney disease; current st…
-
CLINICAL_TRIALS trial_result · 2010-07-02Clinical Trial Update: Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteers [Phase 1]
Phase 1 study comparing absorption of dietary phosphorus when administering FOSRENOL® vs RENVELA® in healthy adult volunteers; completed wit…
-
CLINICAL_TRIALS research · 2010-07-01Clinical Trial Update: Effect of PT on QL, FC, PWV and Biochemical Markers in CRF on Conservative Treatment [NA]
A ClinicalTrials.gov entry describes a study evaluating the impact of physical therapy on quality of life, functional capacity, pulse wave v…
-
CLINICAL_TRIALS research · 2010-06-29Clinical Trial Update: Heart Rate Variability in Chronic Kidney Disease Patients
An update on a clinical trial studying heart rate variability in chronic kidney disease patients, sponsored by National Taiwan University Ho…